| Title |
Medication-overuse headache: a widely recognized entity amidst ongoing debate
|
|---|---|
| Published in |
The Journal of Headache and Pain, July 2018
|
| DOI | 10.1186/s10194-018-0875-x |
| Pubmed ID | |
| Authors |
Nicolas Vandenbussche, Domenico Laterza, Marco Lisicki, Joseph Lloyd, Chiara Lupi, Hannes Tischler, Kati Toom, Fenne Vandervorst, Simone Quintana, Koen Paemeleire, Zaza Katsarava |
| Abstract |
Medication overuse in primary headache disorders is a worldwide phenomenon and has a role in the chronification of headache disorders. The burden of disease on individuals and societies is significant due to high costs and comorbidities. In the Third Edition of the International Classification of Headache Disorders, medication-overuse headache is recognized as a separate secondary entity next to mostly primary headache disorders, although many clinicians see the disease as a sole complication of primary headache disorders. In this review, we explore the historical background of medication-overuse headache, its epidemiology, phenomenology, pathophysiology and treatment options. The review explores relevant unanswered questions and summarizes the current debates in medication-overuse headache. |
X Demographics
The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 5 | 23% |
| Canada | 2 | 9% |
| Latvia | 1 | 5% |
| Venezuela, Bolivarian Republic of | 1 | 5% |
| Uruguay | 1 | 5% |
| Hungary | 1 | 5% |
| Tuvalu | 1 | 5% |
| Mexico | 1 | 5% |
| Brazil | 1 | 5% |
| Other | 1 | 5% |
| Unknown | 7 | 32% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 19 | 86% |
| Scientists | 2 | 9% |
| Practitioners (doctors, other healthcare professionals) | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 171 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 171 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 21 | 12% |
| Student > Bachelor | 20 | 12% |
| Other | 18 | 11% |
| Student > Ph. D. Student | 14 | 8% |
| Researcher | 13 | 8% |
| Other | 31 | 18% |
| Unknown | 54 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 61 | 36% |
| Neuroscience | 12 | 7% |
| Nursing and Health Professions | 11 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 6% |
| Biochemistry, Genetics and Molecular Biology | 7 | 4% |
| Other | 14 | 8% |
| Unknown | 55 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 204. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 August 2023.
All research outputs
#179,924
of 24,317,326 outputs
Outputs from The Journal of Headache and Pain
#27
of 1,466 outputs
Outputs of similar age
#4,055
of 331,024 outputs
Outputs of similar age from The Journal of Headache and Pain
#1
of 32 outputs
Altmetric has tracked 24,317,326 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,466 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,024 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.